Bridgehead International Ltd

Bridgehead International is a leading biopharmaceutical consultancy group, offering a range of services designed to assist clients in achieving extraordinary growth across the product and technology value chain.

Our mission is to work with commercial organisations, government agencies and the investment community to ensure that:

• Life science organisations have the funding, structure and strategic focus to deliver high levels of innovation and financial return

• Patients have rapid and broad access to new innovative medicines, medical devices and diagnostic tools, particularly in areas of high unmet need.

With over 40 consultants and 60 associates in Europe, North America and Asia, Bridgehead provides a powerful combination of strategic, scientific, medical, technical, commercial, economic, decision support, modelling and intellectual property skills and experience.

Bridgehead is globally recognised and renowned for its expertise in:

• Technical and commercial evaluation
• Due diligence and Experts’ Reports
• Forecasting and valuation
• Market access
• Pricing and reimbursement strategy
• Health economics and health technology assessment.